Latest News and Press Releases
Want to stay updated on the latest news?
-
TORONTO and HOUSTON, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQX: MDNAF), a clinical-stage immunotherapy company focused...
-
Medicenna Announces Results of Annual Meeting of Shareholders
-
Medicenna will present and participate in one-on-one meetings at the H.C. Wainwright 27th Annual Global Investment Conference in New York City.